Agenus
AGEN
#8979
Rank
S$0.17 B
Marketcap
S$5.03
Share price
4.27%
Change (1 day)
17.90%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): S$24.46 Million

According to Agenus 's latest financial reports the company's current earnings are S$0.10 Billion. In 2024 the company made an earning of -S$0.15 Billion, an increase over its 2023 earnings that were of -S$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$24.46 M-116.58%
2024 -S$0.15 Billion-28.13%
2023 -S$0.21 Billion-5.5%
2022 -S$0.22 Billion-556.26%
2021 S$47.6 M-130.37%
2020 -S$0.16 Billion73.75%
2019 -S$90.23 Million-48.74%
2018 -S$0.18 Billion34.32%
2017 -S$0.14 Billion-7.16%
2016 -S$0.15 Billion26.55%
2015 -S$0.12 Billion110.24%
2014 -S$53.06 Million49.12%
2013 -S$35.58 Million
2011 -S$24.57 Million-12.25%
2010 -S$28 Million-21.41%
2009 -S$35.62 Million-26.86%
2008 -S$48.71 Million13.72%
2007 -S$42.83 Million-33.4%
2006 -S$64.31 Million-31.84%
2005 -S$94.34 Million9.74%
2004 -S$85.97 Million-0.8%
2003 -S$86.67 Million17.37%
2002 -S$73.84 Million37.83%
2001 -S$53.57 Million55.99%
2000 -S$34.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
S$29.71 B 111,645.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$11.99 B 45,018.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$41.69 B 156,682.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.33 Billion-1,340.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.33 B 38,776.25%๐Ÿ‡บ๐Ÿ‡ธ USA